Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear™ Nucleus® Nexa® System - the world's first and only smart cochlear implant system. The new Cochlear™ Nucleus® ...

Hearing is one of those things most people never think about until it’s gone. For millions living with severe to profound hearing loss, a cochlear implant isn’t just a device. It’s a way back to ...

Cochlear on Monday announced the launch of Cochlear™ Nucleus® Nexa® System in India, describing it as the world’s first and only smart cochlear implant system, coinciding with World Hearing Day.

Wilsons has given its verdict on these big names and it's good. The post Why Cochlear and ResMed shares could be strong buys appeared first on The Motley Fool Australia.

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...

Researchers create the first sex-specific GLP-1 brain atlas, revealing why weight-loss drugs work differently in men and women.

Last month, I caught a bug or allergy of some kind which had me coughing badly for weeks. I don't know about the severity but it was annoying. What was even more annoying was trying to find a decent ...

These companies could be just what the doctor ordered. The post Four ASX healthcare stocks which are looking cheap appeared first on The Motley Fool Australia.

Doctors at the Postgraduate Institute of Medical Education and Research (PGIMER) have successfully performed Tricity’s first SMART Nucleus NEXA CI1032 Slim Perimodiolar cochlear implant surgeries, ...